Vismodegib in the treatment of patients with metastatic basal cell carcinoma (mBCC) and distant metastases: Survival in the pivotal phase II and phase I studies. Lewis, K. D., Sekulic, A., Hauschild, A., Migden, M., Oro, A. E., LoRusso, P., Rudin, C. M., Dirix, L., Solomon, J. A., Hainsworth, J. D., Williams, S., Hou, J., Von Hoff, D. D. AMER SOC CLINICAL ONCOLOGY. 2014

View details for DOI 10.1200/jco.2014.32.15_suppl.9012

View details for Web of Science ID 000358613204298